866-997-4948(US-Canada Toll Free)

20th European Stroke Conference - Post Conference Review and Analysis

Published By :

GlobalData

Published Date : Jun 2011

Category :

Therapeutic Area

No. of Pages : 18 Pages


GlobalData, the industry analysis specialist, has released its new conference alerts, 20th European Stroke Conference - Post Conference Review and Analysis. The conference alert is an essential source of information and analysis on the emerging therapies and new disease management techniques.

The 20th European Stroke Conference was held in Hamburg, Germany between May 24 and May 27, 2011. The four-day conference included discussion on the most recent advances in cerebral circulation and brain function, clinical stroke research and outcomes, meta-analysis, rehabilitation science and surgery. This report entitled 20th European Stroke Conference: Post-Conference Review and Analysis, aims to cover some of the scientific articles released during the course of the conference.

Scope


The report provides complete coverage of conference. Its scope includes -
  • Qualitative analysis of the studies and clinical trials presented at the conference and their impact on the key market dynamics and future treatment paradigm.
  • review of pre- and post-conference KOL/analyst comments
  • Market revenue data for 2010 and forecast forward to 2017 for a specific disease area (if the conference being covered is focused on a specific disease area).
  • Review of key industry trends and events which are likely to impact and change the dynamics of the concerned disease markets in the long run.
Reasons to buy

The report will serve to facilitate your decision making in the concerned therapy areas. It will allow you to -
  • Develop business strategies by understanding the trends and developments that are driving or are expected to drive the market in the concerned disease areas.
  • Explore M&A opportunities by identifying key products and market players.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the market opportunities.
  • Make more informed business decisions from the insightful and in-depth analysis of the market and the factors influencing the same.
Table of Content:

1 Table of contents

1 Table of contents 2

2 20th European Stroke Conference: Post-Conference Key Highlights 3
2.1 Granulocyte-Colony Stimulating Factor (G-CSF) for Mobilizing Bone Marrow Stem Cells in Sub-Acute Stroke: the Stem Cell Trial of Recovery Enhancement after Stroke-2 (STEMS-2) Randomized Controlled Trial 3
2.2 Neuroflo Treatment and Mortality: Results from the SENTIS Randomized, Multi-Center Trial 4
2.3 Fluoxetine for Motor Recovery after Acute Ischemic Stroke (FLAME): A Randomized Placebo Controlled Trial 5
2.4 Long-Term Functional Outcome after Subarachnoid Hemorrhage (SAH): A Systematic Review on Prognostic Determinants 6
2.5 Autologous Bone-Marrow Mononuclear Cells (BM-MNC) in Middle Cerebral Artery Acute Ischemic Stroke: A single-blind controlled Phase I/II trial 7
2.6 The Mechanistic Study of Netrin-1 Protective Effects against Ischemic Stroke 8
2.7 Development of New PARP-1 Inhibitor and Its Role in Ischemic Stroke; Infarct Volume Decreasing Effect and Neuroprotective Mechanisms 9
2.8 Prevotella Intermedia Infection Associate with Atherothrombotic Stroke Periodontal Bacteria Antibody Titration in Ischemic Stroke (PERIODONTITIS) Study 10
2.9 Effect of Allopurinol in Ischemic Stroke Prognosis 11
2.10 Early Safety and Efficacy of Theophylline to Promote Post-Stroke Motor Recovery 12
2.11 Effect of Early Cilostazol in the Acute Phase of Non-Cardioembolic Stroke 13
2.12 The Effectiveness of Dual Antiplatelet Treatment in Acute Ischemic Stroke Patients with Purely Intracranial Stenosis: a Subgroup Analysis of CLAIR Study 14
2.13 Molsidomine Treatment in the Prophylaxis of Delayed Ischemic Neurological Deficit (DIND) and Delayed Brain Infarction Following Subarachnoid Hemorrhage (SAH) 15
2.14 Inhibitors of Oxidative Phosphorilation in Acute Stroke: Preliminary Data from Rats Study 16
2.15 Abbreviations 17
2.16 Disclaimer 18

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *